Sterile Injectable CDMO Market 2024, By Manufacturing Type (Preclinical Manufacturing, Clinical Manufacturing, Commercial Manufacturing), By Services (Stand-alone Services, Integrated Services), By Drug Type (Monoclonal Antibodies (mAbs), Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulins, Blood Factors, Peptide Antibiotics, Others), By End User (Pharmaceutical Companies, Biopharmaceutical Companies, Research Institutes, Others) and Region – Global Dynamics, Trends & Forecast

Number of pages: 200+  |  Report Format: PDF  |  Published date: August, 2024
Historical Years – 2018-2022  |  Base Year – 2023  |  Forecasted Years – 2024 to 2033

A new report titled “Sterile Injectable CDMO (Contract Development and Manufacturing Organization) Market – Forecast to 2033” by Eternal Markets, the global sterile injectable CDMO industry is projected to grow at a compound annual growth rate (CAGR) of 11.2% from 2024 to 2033, reaching a value of USD 27,678.5 million by the end of the forecast period.

Overview

The global sterile injectable CDMO (Contract Development and Manufacturing Organization) Market is experiencing significant growth, driven by the increasing demand for sterile injectable drugs and the growing outsourcing trend in the pharmaceutical industry. Sterile injectables are medications administered through injections that must be free from microbial contamination. CDMOs provide comprehensive services, including drug development, manufacturing, and packaging, to pharmaceutical companies. The market includes various types of sterile injectable drugs, such as biologics, vaccines, and small molecules. The rising prevalence of chronic diseases, the growing biopharmaceutical sector, and the need for specialized manufacturing capabilities are key factors propelling market growth. North America and Europe are leading markets due to the advanced pharmaceutical infrastructure and extensive research and development activities.

Key Visions

  • Estimated CAGR: Around 11.2% over the forecast period (2024-2033).
  • Market Size: Projected to reach USD 27,678.5 million by 2033 from USD 10,345.3 million in 2023.
  • Key Driver: Increasing demand for injectable drugs and outsourcing manufacturing processes.
  • Dominant Segment: Commercial manufacturing segment held the largest market share in 2023.
  • Leading Services: Integrated services segment likely to be the largest revenue contributor by 2033.
  • Leading Region: North America held the largest market share in 2023 due to advanced healthcare infrastructure and robust pharmaceutical industry.

Key Market Drivers

Rising Prevalence of Chronic Diseases: The increasing incidence of chronic conditions such as diabetes, cancer, and cardiovascular diseases is driving the demand for injectable therapies.

Growth in Biopharmaceuticals: The expanding biopharmaceutical sector, which relies heavily on injectable drugs, is boosting the need for sterile manufacturing services.

Outsourcing Trends: Pharmaceutical companies are increasingly outsourcing manufacturing processes to CDMOs to focus on core competencies and reduce operational costs.

Regulatory Compliance: The complexity and high cost of maintaining compliance with stringent regulatory standards are prompting companies to partner with specialized CDMOs.

Technological Advancements: Innovations in sterile manufacturing technologies are enhancing the efficiency and quality of injectable drug production.

Restraining Factors

High Manufacturing Costs: The high cost of setting up and maintaining sterile manufacturing facilities may limit market growth.

Regulatory Challenges: Navigating complex and stringent regulatory requirements can pose significant challenges for market participants.

Quality Control Issues: Ensuring consistent quality and sterility of injectable products is a critical challenge for CDMOs.

Future Scope

Expansion in Emerging Markets: Growth opportunities in emerging markets with expanding healthcare infrastructure and increasing pharmaceutical investments.

Technological Integration: Adoption of advanced technologies such as automation and digitalization to improve manufacturing efficiency and product quality.

Increased Collaborations: Partnerships and collaborations between pharmaceutical companies and CDMOs to accelerate drug development and manufacturing processes.

Diversification of Services: Expansion of service offerings by CDMOs to include comprehensive solutions from development to commercialization.

Regulatory Support: Evolving regulatory frameworks supporting innovation and faster approval processes for sterile injectables.

Major Strategies adopted by key market players.

  • Agreements, Collaborations, and Partnerships: 21%
  • Acquisitions: 15%
  • New Product Launch: _%
  • Other Developments: _%

Geographical Analysis

North America: Dominates the market with the largest share in 2023, driven by advanced healthcare infrastructure, strong pharmaceutical industry, and high adoption of innovative technologies.

Europe: Holds a significant market share due to robust research activities, high healthcare expenditure, and a large number of pharmaceutical companies.

Asia-Pacific: Expected to witness the fastest growth owing to increasing investments in healthcare infrastructure, expanding biopharmaceutical sector, and rising demand for injectable therapies.

Recent Developments

2023: Pfizer announced a major expansion of its sterile injectable manufacturing capabilities to meet growing global demand.

2023: Evonik entered into a strategic partnership with a leading biopharmaceutical company to provide integrated sterile manufacturing services.

2022: Curida AS launched a new state-of-the-art sterile manufacturing facility to enhance its service offerings.

2022: Astral SteriTech received regulatory approval for its new sterile injectable product, expanding its portfolio in the oncology segment.

Scope of the Report:

Global Sterile Injectable CDMO Market, By Manufacturing Type

  • Preclinical Manufacturing
  • Clinical Manufacturing
  • Commercial Manufacturing

Global Sterile Injectable CDMO Market, By Services

  • Stand-alone Services
  • Integrated Services

Global Sterile Injectable CDMO Market, By Drug Type

  • Monoclonal Antibodies (mAbs)
  • Cytokines
  • Insulin
  • Peptide Hormones
  • Vaccines
  • Immunoglobulins
  • Blood Factors
  • Peptide Antibiotics
  • Others

Global Sterile Injectable CDMO Market, By End User

  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Research Institutes
  • Others

Global Sterile Injectable CDMO Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of APAC (RoAPAC)
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • GCC
    • Israel
    • South Africa
    • Rest of MEA

Companies Profiled

● Pfizer
● Abbvie
● Evonik
● Fareva
● Curida AS
● Astral SteriTech
● TriRx Pharmaceutical Services
● Temad Co.
● Aurigene Pharmaceutical Services
● Tianjin Hankang Pharmaceutical Biotechnology
● BioTechnique
● BirgiMefar Group
● Quotient Sciences
● Polfa Tarchomin
● Famar
● Other key players

*The report scope shall be customized as per the requirements

Chapter 1 Global Sterile Injectable CDMO Market Overview
1.1 Introduction
1.2 Drivers for Sterile Injectable CDMO Market
1.3 Restraints for Sterile Injectable CDMO Market
1.4 Opportunities for Sterile Injectable CDMO Market
1.5 Trends for Sterile Injectable CDMO Market
1.6 Macro-economic Factors
1.7 Regulatory Framework
1.8 Opportunity Map Analysis
1.9 Opportunity Orbits
1.10 Market Investment Feasibility Index
1.11 PEST Analysis
1.12 PORTER’S Five Force Analysis
1.13 Go to Market Strategy
1.14 Marketing Strategy
1.15 Technology Roadmap
1.16 Advances in product/services adoption worldwide
1.17 Regional Market Share and BPS Analysis
Chapter 2 Global Sterile Injectable CDMO Market Competitive Analysis
2.1 Market Competition Scenario Analysis, By Company
2.2 Competitor Landscape
2.3 Major Strategies adopted by key market players (2020-2022)
2.4 Recent Developments/Investments/Announcements
2.5 Company Profiles
2.5.1 Pfizer
2.5.1.1 Company Overview
2.5.1.2 Business Description
2.5.1.3 Product Portfolio
2.5.1.4 Key Financials
2.5.1.5 Company Presence & Business Segment Analysis – 2022
2.5.1.6 Key Developments
2.5.1.7 SWOT Analysis
2.5.2 Abbvie
2.5.2.1 Company Overview
2.5.2.2 Business Description
2.5.2.3 Product Portfolio
2.5.2.4 Key Financials
2.5.2.5 Company Presence & Business Segment Analysis – 2022
2.5.2.6 Key Developments
2.5.2.7 SWOT Analysis
2.5.3 Evonik
2.5.3.1 Company Overview
2.5.3.2 Business Description
2.5.3.3 Product Portfolio
2.5.3.4 Key Financials
2.5.3.5 Company Presence & Business Segment Analysis – 2022
2.5.3.6 Key Developments
2.5.3.7 SWOT Analysis
2.5.4 Fareva
2.5.4.1 Company Overview
2.5.4.2 Business Description
2.5.4.3 Product Portfolio
2.5.4.4 Key Financials
2.5.4.5 Company Presence & Business Segment Analysis – 2022
2.5.4.6 Key Developments
2.5.4.7 SWOT Analysis
2.5.5 Curida AS
2.5.5.1 Company Overview
2.5.5.2 Business Description
2.5.5.3 Product Portfolio
2.5.5.4 Key Financials
2.5.5.5 Company Presence & Business Segment Analysis – 2022
2.5.5.6 Key Developments
2.5.5.7 SWOT Analysis
2.5.6 Astral SteriTech
2.5.6.1 Company Overview
2.5.6.2 Business Description
2.5.6.3 Product Portfolio
2.5.6.4 Key Financials
2.5.6.5 Company Presence & Business Segment Analysis – 2022
2.5.6.6 Key Developments
2.5.6.7 SWOT Analysis
2.5.7 TriRx Pharmaceutical Services
2.5.7.1 Company Overview
2.5.7.2 Business Description
2.5.7.3 Product Portfolio
2.5.7.4 Key Financials
2.5.7.5 Company Presence & Business Segment Analysis – 2022
2.5.7.6 Key Developments
2.5.7.7 SWOT Analysis
2.5.8 Temad Co.
2.5.8.1 Company Overview
2.5.8.2 Business Description
2.5.8.3 Product Portfolio
2.5.8.4 Key Financials
2.5.8.5 Company Presence & Business Segment Analysis – 2022
2.5.8.6 Key Developments
2.5.8.7 SWOT Analysis
2.5.9 Aurigene Pharmaceutical Services
2.5.9.1 Company Overview
2.5.9.2 Business Description
2.5.9.3 Product Portfolio
2.5.9.4 Key Financials
2.5.9.5 Company Presence & Business Segment Analysis – 2022
2.5.9.6 Key Developments
2.5.9.7 SWOT Analysis
2.5.10 Tianjin Hankang Pharmaceutical Biotechnology
2.5.10.1 Company Overview
2.5.10.2 Business Description
2.5.10.3 Product Portfolio
2.5.10.4 Key Financials
2.5.10.5 Company Presence & Business Segment Analysis – 2022
2.5.10.6 Key Developments
2.5.10.7 SWOT Analysis
Chapter 3 Global Sterile Injectable CDMO Market Overview
3.1 Global Sterile Injectable CDMO Market Outlook (2017-2032)
3.1.1 Global Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) (2017-2023)
3.1.2 Global Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) (2024-2032)
3.2 Global Sterile Injectable CDMO Market by Region
3.2.1 Global Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
3.2.2 Global Sterile Injectable CDMO Market Attractiveness Analysis by Region, 2023–2032
3.3 Global Sterile Injectable CDMO Market by Manufacturing Type
3.3.1 Global Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Manufacturing Type (2017-2032)
3.3.2 Global Sterile Injectable CDMO Market Attractiveness Analysis by Manufacturing Type, 2023–2032
3.3.3 Global Sterile Injectable CDMO Market Attractiveness Analysis by Region, 2023–2032
3.4 Global Sterile Injectable CDMO Market by Services
3.4.1 Global Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Services (2017-2032)
3.4.2 Global Sterile Injectable CDMO Market Attractiveness Analysis by Services, 2023–2032
3.5 Global Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) by Region
3.5.1 Global Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
3.5.2 Global Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
3.6 Global Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) by Manufacturing Type
3.6.1 Global Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Manufacturing Type (2017-2023)
3.6.2 Global Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Manufacturing Type (2024-2032)
3.7 Global Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) by Services
3.7.1 Global Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Services (2017-2023)
3.7.2 Global Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Services (2024-2032)
3.8 Global Sterile Injectable CDMO Market Y-o-Y Growth Rate Comparison 2018–2032
3.8.1 Global Sterile Injectable CDMO Market Y-o-Y Growth Rate by Region
3.8.2 Global Sterile Injectable CDMO Market Y-o-Y Growth Rate by Manufacturing Type
3.8.3 Global Sterile Injectable CDMO Market Y-o-Y Growth Rate by Services
3.9 Global Sterile Injectable CDMO Market Share Comparison 2017–2032
3.9.1 Global Sterile Injectable CDMO Market Share by Region
3.9.2 Global Sterile Injectable CDMO Market Share by Manufacturing Type
3.9.3 Global Sterile Injectable CDMO Market Share by Services
Chapter 4 North America Sterile Injectable CDMO Market Overview
4.1 North America Market Snapshot
4.1.1 Regional Overview
4.1.1.1 US
4.1.1.2 Canada
4.1.1.3 Mexico
4.2 North America Sterile Injectable CDMO Market Outlook (2017-2032)
4.2.1 North America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) (2017-2023)
4.2.2 North America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) (2024-2032)
4.3 North America Sterile Injectable CDMO Market by Region
4.3.1 North America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
4.3.2 North America Sterile Injectable CDMO Market Attractiveness Analysis by Region, 2023–2032
4.4 North America Sterile Injectable CDMO Market by Manufacturing Type
4.4.1 North America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Manufacturing Type (2017-2032)
4.4.2 North America Sterile Injectable CDMO Market Attractiveness Analysis by Manufacturing Type, 2023–2032
4.4.3 North America Sterile Injectable CDMO Market Attractiveness Analysis by Region, 2023–2032
4.5 North America Sterile Injectable CDMO Market by Services
4.5.1 North America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Services (2017-2032)
4.5.2 North America Sterile Injectable CDMO Market Attractiveness Analysis by Services, 2023–2032
4.6 North America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) by Region
4.6.1 North America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
4.6.2 North America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
4.7 North America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) by Manufacturing Type
4.7.1 North America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Manufacturing Type (2017-2023)
4.7.2 North America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Manufacturing Type (2024-2032)
4.8 North America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) by Services
4.8.1 North America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Services (2017-2023)
4.8.2 North America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Services (2024-2032)
4.9 North America Sterile Injectable CDMO Market Y-o-Y Growth Rate Comparison 2018–2032
4.9.1 North America Sterile Injectable CDMO Market Y-o-Y Growth Rate by Region
4.9.2 North America Sterile Injectable CDMO Market Y-o-Y Growth Rate by Manufacturing Type
4.9.3 North America Sterile Injectable CDMO Market Y-o-Y Growth Rate by Services
4.1 North America Sterile Injectable CDMO Market Share Comparison 2017–2032
4.10.1 North America Sterile Injectable CDMO Market Share by Region
4.10.2 North America Sterile Injectable CDMO Market Share by Manufacturing Type
4.10.3 North America Sterile Injectable CDMO Market Share by Services
Chapter 5 Europe Sterile Injectable CDMO Market Overview
5.1 Europe Market Snapshot
5.1.1 Regional Overview
5.1.1.1 Germany
5.1.1.2 United Kingdom
5.1.1.3 France
5.1.1.4 Italy
5.1.1.5 Spain
5.1.1.6 Russia
5.1.1.7 Rest of Europe
5.2 Europe Sterile Injectable CDMO Market Outlook (2017-2032)
5.2.1 Europe Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) (2017-2023)
5.2.2 Europe Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) (2024-2032)
5.3 Europe Sterile Injectable CDMO Market by Region
5.3.1 Europe Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
5.3.2 Europe Sterile Injectable CDMO Market Attractiveness Analysis by Region, 2023–2032
5.4 Europe Sterile Injectable CDMO Market by Manufacturing Type
5.4.1 Europe Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Manufacturing Type (2017-2032)
5.4.2 Europe Sterile Injectable CDMO Market Attractiveness Analysis by Manufacturing Type, 2023–2032
5.4.3 Europe Sterile Injectable CDMO Market Attractiveness Analysis by Region, 2023–2032
5.5 Europe Sterile Injectable CDMO Market by Services
5.5.1 Europe Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Services (2017-2032)
5.5.2 Europe Sterile Injectable CDMO Market Attractiveness Analysis by Services, 2023–2032
5.6 Europe Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) by Region
5.6.1 Europe Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
5.6.2 Europe Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
5.7 Europe Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) by Manufacturing Type
5.7.1 Europe Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Manufacturing Type (2017-2023)
5.7.2 Europe Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Manufacturing Type (2024-2032)
5.8 Europe Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) by Services
5.8.1 Europe Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Services (2017-2023)
5.8.2 Europe Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Services (2024-2032)
5.9 Europe Sterile Injectable CDMO Market Y-o-Y Growth Rate Comparison 2018–2032
5.9.1 Europe Sterile Injectable CDMO Market Y-o-Y Growth Rate by Region
5.9.2 Europe Sterile Injectable CDMO Market Y-o-Y Growth Rate by Manufacturing Type
5.9.3 Europe Sterile Injectable CDMO Market Y-o-Y Growth Rate by Services
5.1 Europe Sterile Injectable CDMO Market Share Comparison 2017–2032
5.10.1 Europe Sterile Injectable CDMO Market Share by Region
5.10.2 Europe Sterile Injectable CDMO Market Share by Manufacturing Type
5.10.3 Europe Sterile Injectable CDMO Market Share by Services
Chapter 6 Asia Pacific Sterile Injectable CDMO Market Overview
6.1 Asia Pacific Market Snapshot
6.1.1 Regional Overview
6.1.1.1 China
6.1.1.2 India
6.1.1.3 Japan
6.1.1.4 Australia
6.1.1.5 Rest of Asia Pacific
6.2 Asia Pacific Sterile Injectable CDMO Market Outlook (2017-2032)
6.2.1 Asia Pacific Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) (2017-2023)
6.2.2 Asia Pacific Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) (2024-2032)
6.3 Asia Pacific Sterile Injectable CDMO Market by Region
6.3.1 Asia Pacific Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
6.3.2 Asia Pacific Sterile Injectable CDMO Market Attractiveness Analysis by Region, 2023–2032
6.4 Asia Pacific Sterile Injectable CDMO Market by Manufacturing Type
6.4.1 Asia Pacific Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Manufacturing Type (2017-2032)
6.4.2 Asia Pacific Sterile Injectable CDMO Market Attractiveness Analysis by Manufacturing Type, 2023–2032
6.4.3 Asia Pacific Sterile Injectable CDMO Market Attractiveness Analysis by Region, 2023–2032
6.5 Asia Pacific Sterile Injectable CDMO Market by Services
6.5.1 Asia Pacific Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Services (2017-2032)
6.5.2 Asia Pacific Sterile Injectable CDMO Market Attractiveness Analysis by Services, 2023–2032
6.6 Asia Pacific Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) by Region
6.6.1 Asia Pacific Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
6.6.2 Asia Pacific Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
6.7 Asia Pacific Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) by Manufacturing Type
6.7.1 Asia Pacific Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Manufacturing Type (2017-2023)
6.7.2 Asia Pacific Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Manufacturing Type (2024-2032)
6.8 Asia Pacific Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) by Services
6.8.1 Asia Pacific Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Services (2017-2023)
6.8.2 Asia Pacific Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Services (2024-2032)
6.9 Asia Pacific Sterile Injectable CDMO Market Y-o-Y Growth Rate Comparison 2018–2032
6.9.1 Asia Pacific Sterile Injectable CDMO Market Y-o-Y Growth Rate by Region
6.9.2 Asia Pacific Sterile Injectable CDMO Market Y-o-Y Growth Rate by Manufacturing Type
6.9.3 Asia Pacific Sterile Injectable CDMO Market Y-o-Y Growth Rate by Services
6.1 Asia Pacific Sterile Injectable CDMO Market Share Comparison 2017–2032
6.10.1 Asia Pacific Sterile Injectable CDMO Market Share by Region
6.10.2 Asia Pacific Sterile Injectable CDMO Market Share by Manufacturing Type
6.10.3 Asia Pacific Sterile Injectable CDMO Market Share by Services
Chapter 7 South America Sterile Injectable CDMO Market Overview
7.1 South America Market Snapshot
7.1.1 Regional Overview
7.1.1.1 Brazil
7.1.1.2 Argentina
7.1.1.3 Rest of South America
7.2 South America Sterile Injectable CDMO Market Outlook (2017-2032)
7.2.1 South America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) (2017-2023)
7.2.2 South America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) (2024-2032)
7.3 South America Sterile Injectable CDMO Market by Region
7.3.1 South America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
7.3.2 South America Sterile Injectable CDMO Market Attractiveness Analysis by Region, 2023–2032
7.4 South America Sterile Injectable CDMO Market by Manufacturing Type
7.4.1 South America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Manufacturing Type (2017-2032)
7.4.2 South America Sterile Injectable CDMO Market Attractiveness Analysis by Manufacturing Type, 2023–2032
7.4.3 South America Sterile Injectable CDMO Market Attractiveness Analysis by Region, 2023–2032
7.5 South America Sterile Injectable CDMO Market by Services
7.5.1 South America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Services (2017-2032)
7.5.2 South America Sterile Injectable CDMO Market Attractiveness Analysis by Services, 2023–2032
7.6 South America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) by Region
7.6.1 South America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
7.6.2 South America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
7.7 South America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) by Manufacturing Type
7.7.1 South America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Manufacturing Type (2017-2023)
7.7.2 South America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Manufacturing Type (2024-2032)
7.8 South America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) by Services
7.8.1 South America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Services (2017-2023)
7.8.2 South America Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Services (2024-2032)
7.9 South America Sterile Injectable CDMO Market Y-o-Y Growth Rate Comparison 2018–2032
7.9.1 South America Sterile Injectable CDMO Market Y-o-Y Growth Rate by Region
7.9.2 South America Sterile Injectable CDMO Market Y-o-Y Growth Rate by Manufacturing Type
7.9.3 South America Sterile Injectable CDMO Market Y-o-Y Growth Rate by Services
7.1 South America Sterile Injectable CDMO Market Share Comparison 2017–2032
7.10.1 South America Sterile Injectable CDMO Market Share by Region
7.10.2 South America Sterile Injectable CDMO Market Share by Manufacturing Type
7.10.3 South America Sterile Injectable CDMO Market Share by Services
Chapter 8 Middle East and Africa Sterile Injectable CDMO Market Overview
8.1 Middle East and Africa Market Snapshot
8.1.1 Regional Overview
8.1.1.1 GCC
8.1.1.2 South Africa
8.1.1.3 Israel
8.1.1.4 Rest of Middle East and Africa
8.2 Middle East and Africa Sterile Injectable CDMO Market Outlook (2017-2032)
8.2.1 Middle East and Africa Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) (2017-2023)
8.2.2 Middle East and Africa Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) (2024-2032)
8.3 Middle East and Africa Sterile Injectable CDMO Market by Region
8.3.1 Middle East and Africa Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
8.3.2 Middle East and Africa Sterile Injectable CDMO Market Attractiveness Analysis by Region, 2023–2032
8.4 Middle East and Africa Sterile Injectable CDMO Market by Manufacturing Type
8.4.1 Middle East and Africa Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Manufacturing Type (2017-2032)
8.4.2 Middle East and Africa Sterile Injectable CDMO Market Attractiveness Analysis by Manufacturing Type, 2023–2032
8.4.3 Middle East and Africa Sterile Injectable CDMO Market Attractiveness Analysis by Region, 2023–2032
8.5 Middle East and Africa Sterile Injectable CDMO Market by Services
8.5.1 Middle East and Africa Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Services (2017-2032)
8.5.2 Middle East and Africa Sterile Injectable CDMO Market Attractiveness Analysis by Services, 2023–2032
8.6 Middle East and Africa Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) by Region
8.6.1 Middle East and Africa Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
8.6.2 Middle East and Africa Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
8.7 Middle East and Africa Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) by Manufacturing Type
8.7.1 Middle East and Africa Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Manufacturing Type (2017-2023)
8.7.2 Middle East and Africa Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Manufacturing Type (2024-2032)
8.8 Middle East and Africa Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) by Services
8.8.1 Middle East and Africa Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Services (2017-2023)
8.8.2 Middle East and Africa Sterile Injectable CDMO Market Value (US$ Mn) and Volume (Units) Comparison by Services (2024-2032)
8.9 Middle East and Africa Sterile Injectable CDMO Market Y-o-Y Growth Rate Comparison 2018–2032
8.9.1 Middle East and Africa Sterile Injectable CDMO Market Y-o-Y Growth Rate by Region
8.9.2 Middle East and Africa Sterile Injectable CDMO Market Y-o-Y Growth Rate by Manufacturing Type
8.9.3 Middle East and Africa Sterile Injectable CDMO Market Y-o-Y Growth Rate by Services
8.1 Middle East and Africa Sterile Injectable CDMO Market Share Comparison 2017–2032
8.10.1 Middle East and Africa Sterile Injectable CDMO Market Share by Region
8.10.2 Middle East and Africa Sterile Injectable CDMO Market Share by Manufacturing Type
8.10.3 Middle East and Africa Sterile Injectable CDMO Market Share by Services
Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources

License

Single User, Corporate User, Data Pack / Excel
Single User
$3,499
Corporate User
$6,999
Data Pack / Excel
$999
Compare Added ♡ Add to Wishlist♥ Browse Wishlist

Related products

Compare Products
No products were added to compare list
Return to Shop
Electrolyte Drinks Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Food Colors Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Used Cooking Oil Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Nutritional Food and Drink Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Dietary Fibers Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Luxury Wines and Spirits Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Cooking Oils and Fats Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Commercial Seaweeds Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Food Intolerance Products Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Processed Poultry Meat Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Processed Poultry Meat Market 2024, Global Dynamics, Trends & Forecast
VIEW DETAILS